Qsemble Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Qsemble Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-76,793	Closed	-$4.66M	–	397
2026 Q1	$4.66M	Buy	76,793 +48,266	+169%	+$2.81M	0.36%	98
2025 Q4	$1.54M	Sell	28,527 -207,418	-88%	-$9.98M	0.13%	222
2025 Q3	$10.6M	Buy	235,945 +115,006	+95%	+$5.37M	1.04%	3
2025 Q2	$5.6M	Buy	+120,939	New	+$5.94M	0.54%	58
2025 Q1	–	Sell	-33,984	Closed	-$1.92M	–	441
2024 Q4	$1.92M	Buy	33,984 +20,852	+159%	+$1.17M	0.26%	137
2024 Q3	$679K	Sell	13,132 -12,253	-48%	-$575K	0.13%	229
2024 Q2	$1.05M	Buy	+25,385	New	+$1.14M	0.2%	163
2024 Q1	–	Sell	-70,017	Closed	-$3.59M	–	414
2023 Q4	$3.59M	Buy	70,017 +7,117	+11%	+$374K	0.9%	18
2023 Q3	$3.65M	Buy	+62,900	New	+$3.85M	0.68%	51
2023 Q1	–	Sell	-22,900	Closed	-$1.65M	–	248
2022 Q4	$1.65M	Buy	+22,900	New	+$1.73M	1.15%	10

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Qsemble Capital Management's BMY Position: Q2 2026 in Review

Qsemble Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 76,793 shares — an estimated $4.66M sold.

Qsemble Capital Management first reported a position in BMY in Q4 2022 and held it in 10 quarters. The position peaked at $10.6M in Q3 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Qsemble Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Qsemble Capital Management sold 76,793 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.66M.
Qsemble Capital Management first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 10 quarters.
Qsemble Capital Management's Bristol-Myers Squibb position peaked at $10.6M in Q3 2025.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.